Jon Bruce, MD
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $60,328 of the $84,543 with a category attached, or 71.4%. Medical Device Business Services, Inc. accounts for 75.0% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2022 at $40,620 and has fallen 99.3% since, to $297 in 2025. Among surgery clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 232 payments — averaging $364.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$63K
- Intuitive Surgical$16K
- Johnson & Johnson$2K
- AbbVie$924
- Novo Nordisk$869
- W. L. Gore & Associates, Inc.$371
- plus $938 from 16 others
What the payments were for
- Consulting fees$60,32871%
- Travel & lodging$6,2617%
- Food & beverage$4,9276%
- Education$13,02715%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 33 | $63,425 |
| Intuitive Surgical | 48 | $15,578 |
| Johnson & Johnson | 73 | $2,439 |
| AbbVie | 13 | $924 |
| Novo Nordisk | 43 | $869 |
| W. L. Gore & Associates, Inc. | 3 | $371 |
| Medtronic | 3 | $313 |
| Axogen | 1 | $144 |
| Aesculap, Inc. | 1 | $128 |
| Resmed Corp | 1 | $58 |
| Abbott | 1 | $53 |
| Currax Pharmaceuticals LLC | 2 | $34 |
| Heron Therapeutics, Inc. | 1 | $34 |
| Aimmune Therapeutics, Inc. | 1 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Intra-sana Laboratories | 1 | $21 |
| Lucid Diagnostics Inc. | 1 | $21 |
| Eagle Pharmaceuticals, Inc. | 1 | $20 |
| Davol Inc. | 1 | $18 |
| Nalpropion Pharmaceuticals LLC | 1 | $16 |
| Merck | 1 | $13 |
| Covidien LP | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Echelon Flex$53,586
- ECHELON ENDOPATH$48,032
- Da Vinci Surgical System$14,741
- Harmonic$6,362
- ECHELON FLEX Stapler$6,166
- HARMONIC Product Family$6,044
- Creon$750
- ETHICON ENDO-SURGERY Endoscopic Curved Intraluminal Stapler$659
- GORE ENFORM Preperitoneal Biomaterial$350
- ECHELON ENDOPATH Stapler$279
- Wegovy$247
- AVANCE NERVE GRAFT$144
- CAIMAN VESSEL SEALERS$128
- VISTASEAL$102
- Enseal X1$102
How this compares
$84,543 in reported general payments places this provider in the 95th percentile of 970 surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 45 | $49,507 |
| OzempicSemaglutide | 22 | $20,198 |
| Sucralfate | 17 | $1,991 |
| Pantoprazole Sodium | 40 | $371 |
| Lactulose | 13 | $265 |
| Ondansetron OdtOndansetron | 19 | $199 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $85 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $869 | $20,19822 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 970 surgery providers in North Carolina.
Other surgery in Cary
- Paul EnochsCary$595K
- Scott BovardCary$50K
- Brant HenifordCharlotte$831K
- Vedra AugensteinCharlotte$789K
- John MartinieCharlotte$712K
- Dana PortenierDurham$702K
- David IannittiCharlotte$360K
- William HopeWilmington$350K
- Martyn KnowlesRaleigh$311K
- Walter BoydGreenville$311K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.